We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VistaGen Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa

News   Jun 02, 2008

 
VistaGen Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa
 
 
 

RELATED ARTICLES

T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's disease

News

Researchers in Germany discover a potential new target for treating Parkinson's disease

READ MORE

The “Traffic Cop” Protein Which Gives Progenitor Cells Permission to Differentiate

News

Knowledge of this dictating protein may help find therapies for the injured brain and affect glial tumor cell research

READ MORE

Modified Form of Botox Could Replace Opioids as Treatment for Chronic Pain

News

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE